Bortlik M - Search Results

1

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.

Mitrova K, Pipek B, Bortlik M, Bouchner L, Brezina J, Douda T, Drasar T, Drastich P, Falt P, Klvana P, Leksa V, Novotny A, Svoboda P, Skorpik J, Ulbrych J, Veinfurt M, Zborilova B, Lukas M, Duricova D. Mitrova K, et al. Among authors: bortlik m. Therap Adv Gastroenterol. 2021 Aug 7;14:17562848211032790. doi: 10.1177/17562848211032790. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34394725 Free PMC article.

2

[Toxic megacolon].

Bortlík M, Lukás M. Bortlík M, et al. Cas Lek Cesk. 2001 Oct 11;140(20):619-23. Cas Lek Cesk. 2001. PMID: 11787211 Review. Czech.

3

[Adverse effects of nonsteroidal antirheumatic agents on the digestive tract].

Lukás M, Chalupná P, Adamec S, Bortlík M, Novotný A. Lukás M, et al. Among authors: bortlik m. Sb Lek. 2002;103(2):265-72. Sb Lek. 2002. PMID: 12688151 Czech.

4

Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology.

Bortlik M, Vitkova I, Papezova M, Kohoutova M, Novotny A, Adamec S, Chalupna P, Lukas M. Bortlik M, et al. World J Gastroenterol. 2006 Jun 28;12(24):3901-5. doi: 10.3748/wjg.v12.i24.3901. World J Gastroenterol. 2006. PMID: 16804979 Free PMC article.

5

What is the origin of ulcerative colitis? Still more questions than answers.

Lukas M, Bortlik M, Maratka Z. Lukas M, et al. Among authors: bortlik m. Postgrad Med J. 2006 Oct;82(972):620-5. doi: 10.1136/pmj.2006.047035. Postgrad Med J. 2006. PMID: 17068271 Free PMC article. Review.

6

Nonadherence in inflammatory bowel disease: results of factor analysis.

Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Cervený P, et al. Among authors: bortlik m. Inflamm Bowel Dis. 2007 Oct;13(10):1244-9. doi: 10.1002/ibd.20189. Inflamm Bowel Dis. 2007. PMID: 17538983

7

Fatal myelotoxicity after azathioprine treatment.

Slanar O, Chalupná P, Novotný A, Bortlík M, Krska Z, Lukás M. Slanar O, et al. Among authors: bortlik m. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):661-5. doi: 10.1080/15257770802143905. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600523

8

Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease.

Slanar O, Bortlík M, Buzková H, Donoval R, Pechandová K, Sebesta I, Lukás M, Perlík F. Slanar O, et al. Among authors: bortlik m. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):835-8. doi: 10.1080/15257770802146478. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600549

9

Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.

Lukas M, Drastich P, Konecny M, Gionchetti P, Urban O, Cantoni F, Bortlik M, Duricova D, Bulitta M. Lukas M, et al. Among authors: bortlik m. Inflamm Bowel Dis. 2010 Jul;16(7):1180-6. doi: 10.1002/ibd.21161. Inflamm Bowel Dis. 2010. PMID: 19885903

10

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.

Malickova K, Lakatos PL, Bortlik M, Komarek V, Janatkova I, Lukas M. Malickova K, et al. Among authors: bortlik m. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):144-50. doi: 10.1097/MEG.0b013e32832f5c7e. Eur J Gastroenterol Hepatol. 2010. PMID: 19927001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page